Compass Pathways
Pre-clinicalCompass is a biotechnology company dedicated to accelerating patient access and experience to evidence-based innovation in mental health care.
Founded
2016
Focus
Small MoleculesPsychedelics
About
Compass is a biotechnology company dedicated to accelerating patient access and experience to evidence-based innovation in mental health care.
Funding History
3Total raised: $251.6M
IPO$146.6MUndisclosedSep 18, 2020
Series B$80MAtai Life SciencesJun 15, 2020
Series A$25MAtai Life SciencesJun 15, 2018
Company Info
TypePrivate
Founded2016
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile